William Resides
Vorstandsvorsitzender bei BIOREGENX, INC.
Vermögen: 661 572 $ am 31.05.2024
Aktive Positionen von William Resides
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| BIOREGENX, INC. | Direktor/Vorstandsmitglied | 08.03.2024 | - |
| Vorstandsvorsitzender | 08.03.2024 | - |
Karriereverlauf von William Resides
Ehemalige bekannte Positionen von William Resides
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
NuLife Sciences, Inc.
 NuLife Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services NuLife Sciences, Inc. a biomedical company, which engages in advancing human organ transplant and tissue repair technology, and medical research. The company was founded by Derek Cahill on October 15, 2013 and is headquartered in Newport Beach, CA. | Vorstandsvorsitzender | 02.01.2019 | - |
| Gründer | 02.01.2019 | - | |
BioRegenx, Inc.
 BioRegenx, Inc. Pharmaceuticals: OtherHealth Technology Part of Findit, Inc., BioRegenx, Inc. is a holding company that consists of Microvascular Health Solutions, LLC, My Body RX, LLC, and NuLife Sciences, Inc. The company is based in Chattanooga, TN. The company and its subsidiaries offer 360-degree solutions, which include leading-edge testing technologies and nutraceutical solutions. The patented Endocalyx Pro™ and additional synergistic dietary supplements sold under the My Body RX brand are part of the nutraceuticals offered. The customer base of BioRegenx subsidiaries includes medical professionals, brand partners, and consumers from throughout North America. The CEO of the company is William Resides. BioRegenx was acquired by Findit, Inc. on March 31, 2023. | Direktor/Vorstandsmitglied | - | - |
| Vorstandsvorsitzender | - | - | |
| Gründer | - | - |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Chief Executive Officer | 3 |
| Director/Board Member | 2 |
| Founder | 2 |
Sektoral
| Health Technology | 2 |
| Technology Services | 2 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BIOREGENX, INC. | Technology Services |
| Private Unternehmen | 2 |
|---|---|
BioRegenx, Inc.
BioRegenx, Inc. Pharmaceuticals: OtherHealth Technology Part of Findit, Inc., BioRegenx, Inc. is a holding company that consists of Microvascular Health Solutions, LLC, My Body RX, LLC, and NuLife Sciences, Inc. The company is based in Chattanooga, TN. The company and its subsidiaries offer 360-degree solutions, which include leading-edge testing technologies and nutraceutical solutions. The patented Endocalyx Pro™ and additional synergistic dietary supplements sold under the My Body RX brand are part of the nutraceuticals offered. The customer base of BioRegenx subsidiaries includes medical professionals, brand partners, and consumers from throughout North America. The CEO of the company is William Resides. BioRegenx was acquired by Findit, Inc. on March 31, 2023. | Health Technology |
NuLife Sciences, Inc.
NuLife Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services NuLife Sciences, Inc. a biomedical company, which engages in advancing human organ transplant and tissue repair technology, and medical research. The company was founded by Derek Cahill on October 15, 2013 and is headquartered in Newport Beach, CA. | Commercial Services |
- Börse
- Insiders
- William Resides
- Erfahrung
